Effectiveness of TMS in Therapy
TMS treatment has been approved by FDA since 2008 for patients with depression who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.
Controlled clinical studies¹ applying TMS on patients for major depression showed that:
Approximately 1 out of 2 patients experience significant improvement in depression symptoms.
Approximately 1 out of 3 patients experienced complete symptom relief after the full TMS therapy.
Advantages of TMS Compared to Other Treatments
Targeted modulation of pre-frontal networks
Non-invasive and well-tolerated
No systemic side effects and safe²
No cognitive side effects
Suitable for long-term treatment